166 related articles for article (PubMed ID: 29111174)
21. Proton therapy in stage II-IV non-small cell lung cancer: pattern of care and impact on trial accrual.
Zhu HJ; Nichols RC; Henderson RH; Morris CG; Pham DC; Jones L; Hoppe BS
Acta Oncol; 2018 May; 57(5):692-693. PubMed ID: 29103341
[No Abstract] [Full Text] [Related]
22. Clinical-epidemiological study on advanced non-small cell lung cancer.
Miron L; Bosanceanu M; Filimon R; Petrariu FD
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):492-6. PubMed ID: 25076720
[TBL] [Abstract][Full Text] [Related]
23. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
24. Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.
Girard N; Corral J; Cortinovis D; Heigener DF
Clin Lung Cancer; 2017 Mar; 18(2):e89-e97. PubMed ID: 27865625
[TBL] [Abstract][Full Text] [Related]
25. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
[TBL] [Abstract][Full Text] [Related]
26. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
27. Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies.
Locher C; Debieuvre D; Coëtmeur D; Goupil F; Molinier O; Collon T; Dayen C; Le Treut J; Asselain B; Martin F; Blanchon F; Grivaux M
Lung Cancer; 2013 Jul; 81(1):32-8. PubMed ID: 23541463
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
[TBL] [Abstract][Full Text] [Related]
31. Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.
Zemanova M; Jakopovic M; Stanic K; Łazar-Poniatowska M; Vrankar M; Rusu P; Ciuleanu T; Radosavljevic D; Bogos K; Nawrocki S
Radiol Oncol; 2020 Oct; 54(4):447-454. PubMed ID: 33048837
[TBL] [Abstract][Full Text] [Related]
32. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
34. Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.
Goulart BH; Reyes CM; Fedorenko CR; Mummy DG; Satram-Hoang S; Koepl LM; Blough DK; Ramsey SD
J Oncol Pract; 2013 Jan; 9(1):42-50. PubMed ID: 23633970
[TBL] [Abstract][Full Text] [Related]
35. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung Cancer.
Dawe DE; Pond GR; Ellis PM
Clin Lung Cancer; 2016 Nov; 17(6):563-572.e2. PubMed ID: 27374398
[TBL] [Abstract][Full Text] [Related]
37. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
38. Incidence and survival from lung cancer in Greenland is comparable to survival in the Nordic countries.
Gelvan A; Risum S; Langer SW
Dan Med J; 2015 Apr; 62(4):A5033. PubMed ID: 25872548
[TBL] [Abstract][Full Text] [Related]
39. Patterns of care of nonsmall cell lung cancer patients in China and implications for survival.
He Y; Yu XQ; Luo Q; Xu X; Wang Y; Li S; Shan B
J Cancer Res Ther; 2018 Jun; 14(Supplement):S410-S415. PubMed ID: 29970698
[TBL] [Abstract][Full Text] [Related]
40. Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan.
Kuwabara K; Matsuda S; Fushimi K; Anan M; Ishikawa KB; Horiguchi H; Hayashida K; Fujimori K
Tohoku J Exp Med; 2009 Jan; 217(1):29-35. PubMed ID: 19155605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
